A comprehensive approach that will target the top drug threat identified by the local DEA division while continuing to focus on drug trafficking, violence, and crime reduction.

Illicit stimulants, specifically cocaine and methamphetamine, remain a pervasive drug threat in Pennsylvania. PFD offices, state/local law enforcement agencies, and other stakeholders throughout Pennsylvania report persistent increases since 2017 in various indicators that demonstrate availability, such as the total quantity of illicit stimulants seized by law enforcement, identification of seized...

The increasing availability of illicit opioids is the most significant drug threat in Pennsylvania. The Philadelphia Field Division (PFD) monitors this threat closely, periodically reviewing multiple data indicators, in conjunction with investigative information, to continually assess the threat, then share analytical findings with stakeholders in federal, state, and municipal governments.

On behalf of the nearly 10,000 men and women of the Drug Enforcement Administration that are serving today across the United States and in nearly 70 countries around the world, I want to welcome the United States Postal Service, and all of you watching via livestream, to DEA Headquarters and...

DEA Acting Administrator Timothy Shea delivers remarks at a press conference in the DEA-New England offices in Boston, Mass.

In 2019 alone, Mexican cartels shipped hundreds of thousands of pounds of methamphetamine in tractor trailers and personal vehicles across our Southwest border and onto our nation’s highways — then headed straight for our cities and towns across America.

Due to the efforts of DEA and our partners, from January 2017 through August 2020, we have seen the number of opioid prescriptions drop nearly 37 percent, a reduction in over 47 percent of opioids dispensed, and most importantly -- an 18 percent drop in prescription overdose deaths over the...

DEA Acting Administrator Timothy Shea Delivers Remarks at the Operation DisrupTor Press Conference Department of Justice, Washington, D.C. September 22, 2020

The Drug Enforcement Administration (DEA) Philadelphia Field Division (PFD) is advising law enforcement and public health counterparts of the increased availability of counterfeit controlled prescription drugs (CPDs) – commonly sold as legitimate CPDs with most containing fentanyl/ fentanyl-related compounds (FRC) – in Pennsylvania and Delaware.

While the presence of fentanyl powder (lethal in doses as small as two milligrams) poses a public safety threat, the ingestion of fentanyl via vaping poses a threat of unknown consequences to the user and those nearby.